Pajno Giovanni Battista, La Grutta Stefania, Barberio Giovanni, Canonica Giorgio Walter, Passalacqua Giovanni
Pediatric Division II, University Hospital, Messina, Italy.
J Allergy Clin Immunol. 2002 Apr;109(4):627-9. doi: 10.1067/mai.2002.122844.
With respect to allergy, the possibility of cross-reactivity between snail and mite is well recognized, and anecdotal reports suggesting that allergen immunotherapy with mite extract can worsen snail-induced allergy exist.
We describe the effect of immunotherapy in 4 children with snail-mite allergy.
Four children (1 boy and 3 girls; 9-13 years of age) had consistent clinical histories (mild immediate respiratory symptoms after ingestion) and positive skin reactions for allergy to snail. They also had mite-induced asthma and were therefore prescribed subcutaneous specific immunotherapy and subsequently followed.
Several months (8-25) after starting immunotherapy, all children experienced life-threatening reactions, anaphylaxis, and respiratory failure after inadvertent ingestion of snail. Skin reactivity to the fresh food increased in all patients.
This observation confirms that in patients with combined mite-snail allergy, immunotherapy should be avoided.
关于过敏,蜗牛和螨虫之间存在交叉反应的可能性已得到充分认识,并且有轶事报道表明,用螨虫提取物进行变应原免疫疗法可能会加重蜗牛引起的过敏。
我们描述了免疫疗法对4名蜗牛 - 螨虫过敏儿童的影响。
4名儿童(1名男孩和3名女孩;9 - 13岁)有一致的临床病史(摄入后出现轻度速发型呼吸道症状)且对蜗牛过敏的皮肤反应呈阳性。他们还患有螨虫诱发的哮喘,因此接受了皮下特异性免疫疗法并随后进行随访。
开始免疫疗法数月(8 - 25个月)后,所有儿童在无意中摄入蜗牛后均出现危及生命的反应、过敏反应和呼吸衰竭。所有患者对新鲜食物的皮肤反应性均增加。
该观察结果证实,对于合并螨虫 - 蜗牛过敏的患者,应避免进行免疫疗法。